Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 1998 Oct;74(5):331–333. doi: 10.1136/sti.74.5.331

Effectiveness of patient delivered partner medication for preventing recurrent Chlamydia trachomatis

P Kissinger, R Brown, K Reed, J Salifou, A Drake, T A Farley, D H Martin
PMCID: PMC1758141  PMID: 10195027

Abstract

OBJECTIVE: To determine if providing Chlamydia trachomatis infected women with medication to deliver to their sex partner(s) could reduce recurrent chlamydia infections compared with the standard partner referral method. STUDY DESIGN: A observational cohort study of 178 women, 14-39 years old attending a family planning clinic, diagnosed and treated for C trachomatis between October 1993 and December 1994 was conducted (43 received patient delivered partner medication (PDPM) and 135 received partner referral cards). Women were retested before or at their annual visit. RESULTS: The mean time of follow up was 17.7 months (SD 7.7). The PDPM group (n = 43) was similar to partner referral group (n = 135) for age, race, contraceptive method, history of an STD, and follow up time. The annual recurrent infection rate was lower among the PDPM group compared with the partner referral group (11.5% v 25.5%, p < 0.05). After adjusting for age in logistic regression, women in the PDPM group were less likely than women in the partner referral group to have an incident C trachomatis infection (OR 0.37, 95% CI 0.15-0.97, p < 0.05). CONCLUSION: These findings suggest that patient delivered partner medication can protect women from recurrent C trachomatis infection compared with the standard partner referral approach. Prospective studies with larger sample sizes are under way. 




Full Text

The Full Text of this article is available as a PDF (98.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blythe M. J., Katz B. P., Batteiger B. E., Ganser J. A., Jones R. B. Recurrent genitourinary chlamydial infections in sexually active female adolescents. J Pediatr. 1992 Sep;121(3):487–493. doi: 10.1016/s0022-3476(05)81812-8. [DOI] [PubMed] [Google Scholar]
  2. Cates W., Jr, Rothenberg R. B., Blount J. H. Syphilis control. The historic context and epidemiologic basis for interrupting sexual transmission of Treponema pallidum. Sex Transm Dis. 1996 Jan-Feb;23(1):68–75. doi: 10.1097/00007435-199601000-00013. [DOI] [PubMed] [Google Scholar]
  3. Cates W., Jr, Wasserheit J. N. Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol. 1991 Jun;164(6 Pt 2):1771–1781. doi: 10.1016/0002-9378(91)90559-a. [DOI] [PubMed] [Google Scholar]
  4. Cates W., Jr, Wasserheit J. N. Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol. 1991 Jun;164(6 Pt 2):1771–1781. doi: 10.1016/0002-9378(91)90559-a. [DOI] [PubMed] [Google Scholar]
  5. Fortenberry J. D., Evans D. L. Routine screening for genital Chlamydia trachomatis in adolescent females. Sex Transm Dis. 1989 Oct-Dec;16(4):168–172. doi: 10.1097/00007435-198910000-00002. [DOI] [PubMed] [Google Scholar]
  6. Katz B. P., Danos C. S., Quinn T. S., Caine V., Jones R. B. Efficiency and cost-effectiveness of field follow-up for patients with Chlamydia trachomatis infection in a sexually transmitted diseases clinic. Sex Transm Dis. 1988 Jan-Mar;15(1):11–16. doi: 10.1097/00007435-198801000-00003. [DOI] [PubMed] [Google Scholar]
  7. Katz B. P., Zwickl B. W., Caine V. A., Jones R. B. Compliance with antibiotic therapy for Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Dis. 1992 Nov-Dec;19(6):351–354. [PubMed] [Google Scholar]
  8. Patton D. L., Kuo C. C. Histopathology of Chlamydia trachomatis salpingitis after primary and repeated reinfections in the monkey subcutaneous pocket model. J Reprod Fertil. 1989 Mar;85(2):647–656. doi: 10.1530/jrf.0.0850647. [DOI] [PubMed] [Google Scholar]
  9. Patton D. L., Wølner-Hanssen P., Cosgrove S. J., Holmes K. K. The effects of Chlamydia trachomatis on the female reproductive tract of the Macaca nemestrina after a single tubal challenge following repeated cervical inoculations. Obstet Gynecol. 1990 Oct;76(4):643–650. [PubMed] [Google Scholar]
  10. Ramstedt K., Forssman L., Johannisson G. Contact tracing in the control of genital Chlamydia trachomatis infection. Int J STD AIDS. 1991 Mar-Apr;2(2):116–118. doi: 10.1177/095646249100200208. [DOI] [PubMed] [Google Scholar]
  11. Stamm W. E., Hicks C. B., Martin D. H., Leone P., Hook E. W., 3rd, Cooper R. H., Cohen M. S., Batteiger B. E., Workowski K., McCormack W. M. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA. 1995 Aug 16;274(7):545–549. [PubMed] [Google Scholar]
  12. Steen R., Soliman C., Bucyana S., Dallabetta G. Partner referral as a component of integrated sexually transmitted disease services in two Rwandan towns. Genitourin Med. 1996 Feb;72(1):56–59. doi: 10.1136/sti.72.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Washington A. E., Johnson R. E., Sanders L. L., Jr Chlamydia trachomatis infections in the United States. What are they costing us? JAMA. 1987 Apr 17;257(15):2070–2072. [PubMed] [Google Scholar]
  14. Washington A. E., Katz P. Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000. JAMA. 1991 Nov 13;266(18):2565–2569. [PubMed] [Google Scholar]
  15. van de Laar M. J., Termorshuizen F., van den Hoek A. Partner referral by patients with gonorrhea and chlamydial infection. Case-finding observations. Sex Transm Dis. 1997 Jul;24(6):334–342. doi: 10.1097/00007435-199707000-00005. [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES